Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Forecast to 2030

Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Forecast to 2030 – Regional Analysis – by Service Type (Lyophilization Cycle Development, Clinical Manufacturing, Commercial Manufacturing, and Freeze Drying Analytical Services) and End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Other)

Send Enquiry

$2,485$3,885

Description

The Middle East & Africa lyophilization services for biopharmaceuticals market was valued at US$ 63.68 million in 2023 and is expected to reach US$ 97.55 million by 2028; it is estimated to grow at a CAGR of 8.9% from 2023 to 2028.

Rising Demand for Lyophilized Products Fuels the Middle East & Africa Lyophilization Services for Biopharmaceuticals Market

Lyophilization is a freeze drying method that removes water from the material to extend its stability and shelf life. The products processed under lyophilization are frozen under high vacuum that is majorly used for application in pharmaceutical industries to manufacture high quality and affordable products. Many new parenteral products, including biotechnology-derived products, in-vitro diagnostics, and anti-infectives, are manufactured as lyophilized products. Many antibiotics such as some cephalosporins, semi-synthetic penicillin, erythromycin salts, chloramphenicol, and doxycycline are made by the lyophilization process. Low bioburden is expected when batching antibiotics formulations, which can be attained using lyophilization. Similarly, a few other dosage forms such as methylprednisolone sodium succinate, hydrocortisone sodium succinate, and many biotechnology-derived products are lyophilized.

Additionally, the number of biopharmaceuticals being developed and manufactured has increased considerably in recent years. Although lyophilization has been used for more than half a century in the drug product manufacturing industry owing to its ability to stabilize and extend the shelf life of pharmaceutical products, thus interest of biopharmaceutical manufacturers continues to grow, mainly due to the increasing number of biological drug development. Drug developers are focusing on adopting lyophilization as it can extend the shelf life of small and large-molecule drugs. The prevalence of formulation stability challenges for complex APIs and biologics has resulted in the adoption of lyophilization among most pharmaceutical and biotech manufacturers. Further, lyophilization become important in the biotech industry, as several suppliers are introducing lyo-ready or pre-lyophilized products to the marketplace. As a result, the demand for lyophilization services is growing rapidly, which is driving the growth of the Middle East & Africa lyophilization services for biopharmaceuticals market.

Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Overview

The Middle East & Africa lyophilization services for biopharmaceuticals market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to account for the largest market share and is expected to develop moderately in the Middle East & Africa. The market growth is attributed to various factors, such as significant development in pharmaceutical industries, the awareness about the biopharmaceutical products, and the geographic expansion of market players.

Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Revenue and Forecast to 2028 (US$ Mn)

Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Segmentation

The Middle East & Africa lyophilization services for biopharmaceuticals market is segmented service type, end user, and country.

Based on service type, the Middle East & Africa lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest market share in 2023.

Based on end-user, the Middle East & Africa lyophilization services for biopharmaceuticals market is categorized into pharmaceutical & biotechnology companies, research institutes, and other. The pharmaceutical & biotechnology companies segment held the largest market share in 2023.

Based on country, the Middle East & Africa lyophilization services for biopharmaceuticals market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa lyophilization services for biopharmaceuticals market share in 2023.

ABB, Azbil Corporation, Busch, LLC, Curia Global Inc, Jubilant HollisterStier LLC., and Labconco are some of the leading companies operating in the Middle East & Africa lyophilization services for biopharmaceuticals market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 8.9% CAGR, the Middle East & Africa Lyophilization Services for Biopharmaceuticals Market is speculated to be worth US$ 97.55 million by 2028, says The Research Team

According to The Research Team’ research, the Middle East & Africa lyophilization services for biopharmaceuticals market was valued at US$ 63.68 million in 2023 and is expected to reach US$ 97.55 million by 2028, registering a CAGR of 8.9% from 2023 to 2028. Rising demand for lyophilized products and rapid growth in contract manufacturing and lyophilization services are among the critical factors attributed to the Middle East & Africa lyophilization services for biopharmaceuticals market expansion.

There is a lot of scope for applying RNA interference (RNAi) for cancer treatment. RNAi has become a powerful technology for gene function studies and can be used in therapeutic applications. Moreover, after more than 30 years of accumulation, monoclonal antibody drugs have become well-deserved mainstream branches in the field of medicine, from target development to technological improvement. The development of a successful subcutaneous antibody therapy requiring chronic administration at high dosing, particularly when coupled with a prefilled syringe and autoinjector device for at-home administration, depends on the development of a stable formulation at high concentration. To avoid the instability of the aqueous antibody solution, products are stored in a lyophilized (freeze-dried) state. These compounds regularly require freeze-drying to maintain the integrity of the formulation or vehicle to target the small interfering RNA (siRNA) in the body. The long-term stability of therapeutic candidates is necessary for their clinical applications. For most nanoparticle systems formulated in aqueous solutions, lyophilization or freeze-drying is a standard method to ensure long-term stability. Therefore, the rising number of siRNA and antibody-based formulations is expected to become a prevalent trend in the Middle East & Africa lyophilization services for biopharmaceuticals market in the coming years.

On the contrary, demerits associated with lyophilization process hampers on the growth of Middle East & Africa lyophilization services for biopharmaceuticals market.

Based on service type, the Middle East & Africa lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held 29.5% share of Middle East & Africa lyophilization services for biopharmaceuticals market in 2023, amassing US$ 18.75 million. It is projected to garner US$ 27.11 million by 2028 to expand at 7.6% CAGR during 2023–2028.

Based on end user, the Middle East & Africa lyophilization services for biopharmaceuticals market is segmented into pharmaceutical & biotechnology companies, research institutes, and other. The pharmaceutical & biotechnology companies segment held 76.4% share of Middle East & Africa lyophilization services for biopharmaceuticals market in 2023, amassing US$ 48.65 million. It is projected to garner US$ 75.19 million by 2028 to expand at 9.1% CAGR during 2023–2028.

Based on country, the Middle East & Africa lyophilization services for biopharmaceuticals market has been categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 39.3% share of Middle East & Africa lyophilization services for biopharmaceuticals market in 2023. It was assessed at US$ 25.03 million in 2023 and is likely to hit US$ 37.21 million by 2028, exhibiting a CAGR of 8.2% during 2023–2028.

Key players operating in the Middle East & Africa lyophilization services for biopharmaceuticals market are ABB, Azbil Corporation, Busch, LLC, Curia Global Inc, Jubilant HollisterStier LLC., and Labconco, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa lyophilization services for biopharmaceuticals market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa lyophilization services for biopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Research Team Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – by Service Type
1.3.2 Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – by End User
1.3.3 Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – by Country
2. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Key Market Dynamics
5.1 Market Driver
5.1.1 Rising Demand for Lyophilized Products
5.1.2 Rapid Growth in Contract Manufacturing and Lyophilization Services
5.2 Market Restraints
5.2.1 Demerits Associated with Lyophilization Process
5.3 Market Opportunities
5.3.1 Launch of Advanced Lyophilization Technology
5.4 Future Trends
5.4.1 Growing Number of siRNA and Antibody-Based Formulations
5.5 Impact Analysis of Drivers and Restraints
6. Lyophilization Services for Biopharmaceuticals Market – Middle East & Africa Analysis
6.1 Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Revenue Forecast and Analysis
7. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 – by Service Type
7.1 Overview
7.2 Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
7.3 Commercial Manufacturing
7.3.1 Overview
7.3.2 Commercial Manufacturing: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Clinical Manufacturing
7.4.1 Overview
7.4.2 Clinical Manufacturing: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Lyophilization Cycle Development
7.5.1 Overview
7.5.2 Lyophilization Cycle Development: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Freeze Drying Analytical Services
7.6.1 Overview
7.6.2 Freeze Drying Analytical Services: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 – by End User
8.1 Overview
8.2 Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Companies
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Research Institutes
8.4.1 Overview
8.4.2 Research Institutes: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 – Country Analysis
9.1 Overview
9.1.1 Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
9.1.1.1 Saudi Arabia: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 Saudi Arabia: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.3 Saudi Arabia: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020–2028 (US$ Million)
9.1.1.1.4 Saudi Arabia: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User, 2020–2028 (US$ Million)
9.1.1.2 South Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 South Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.2.3 South Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020–2028 (US$ Million)
9.1.1.2.4 South Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User, 2020–2028 (US$ Million)
9.1.1.3 UAE: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 UAE: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.3 UAE: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020–2028 (US$ Million)
9.1.1.3.4 UAE: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User, 2020–2028 (US$ Million)
9.1.1.4 Rest of Middle East & Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020–2028 (US$ Million)
9.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User, 2020–2028 (US$ Million)
10. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Middle East & Africa Lyophilization Services for Biopharmaceuticals Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 ABB
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Azbil Corporation
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Busch LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Curia Global Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Jubilant HollisterStier LLC.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Labconco Corp
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
12. Appendix
12.1 About The Research Team
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Saudi Arabia: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Saudi Arabia: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 3. South Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. South Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. UAE: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. UAE: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Rest of Middle East & Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Rest of Middle East & Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Recent Inorganic Growth Strategies in the Middle East & Africa Lyophilization Services for Biopharmaceuticals Market
Table 10. Recent Organic Growth Strategies in the Middle East & Africa Lyophilization Services for Biopharmaceuticals Market
Table 11. Glossary of Terms

LIST OF FIGURES

Figure 1. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Segmentation
Figure 2. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Country
Figure 3. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Overview
Figure 4. Commercial Manufacturing Segment Held Largest Share of Service Type Segment in Middle East & Africa Lyophilization Services for Biopharmaceuticals Market
Figure 5. South Africa Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Impact Analysis of Drivers and Restraint
Figure 9. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
Figure 11. Commercial Manufacturing: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Clinical Manufacturing: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lyophilization Cycle Development: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Freeze Drying Analytical Services: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
Figure 16. Pharmaceutical and Biotechnology Companies: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Research Institutes: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Middle East & Africa Lyophilization Services for Biopharmaceuticals Market, by Key Country – Revenue (2022) (US$ Million)
Figure 20. Saudi Arabia: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. South Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. UAE: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Rest of Middle East & Africa: Middle East & Africa Lyophilization Services for Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Growth Strategies in the Middle East & Africa Lyophilization Services for Biopharmaceuticals Market

The List of Companies – Middle East & Africa Lyophilization Services for Biopharmaceuticals Market

o ABB
o Azbil Corporation
o Busch, LLC
o Curia Global Inc
o Jubilant HollisterStier LLC.
o Labconco

Reviews

There are no reviews yet.

Be the first to review “Middle East & Africa Lyophilization Services for Biopharmaceuticals Market Forecast to 2030”